Related Experiment Video
Updated: Feb 8, 2026

In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
Tanshinone IIA effects on ovarian cancer cell line
Nan Li1, Liang Yang2, Baolian Zhang3
1Department of Gynecology, the Second Hospital of Hebei Medical University, Shijiazhuang, China.
Objectives:
To explore the potential therapeutic effect of Tanshinone IIA against ovarian cancer in vitro and elucidate the underlying molecular mechanism.
Methods:
The cell survival upon Tanshinone IIA treatment was determined by the clonogenic assay. Cell apoptosis was analysed by Annexin V/propidium iodide double staining. The cleaved caspase-3/poly ADP-ribose polymerase and apoptosis-related factors were quantified by Western blotting. The relative expression of microRNAs (miRs) was determined by real-time polymerase chain reaction.
Key Findings:
Tanshinone IIA treatment induced significant apoptosis in TOV-21G cells. Tanshinone suppressed survivin expression while not affected Bax, Bcl-2 and Bcl-xL. We further predicted and experimentally confirmed overexpression of miR-205 in TOV-21G, which ectopic significantly inhibited survivin and promoted cell apoptosis. miR-205-specific antagonist completely abrogated the cell suppressive effect of Tanshinone IIA.
Conclusions:
Our data suggested that Tanshinone IIA induced cell apoptosis in ovarian carcinoma TOV-21G cells via direct upregulation of miR-205. Our study highlighted the potential therapeutic application of Tanshinone IIA against ovarian malignancy.
Insights
Tanshinone IIA induces ovarian cancer cell death by increasing microRNA-205 (miR-205) levels, which inhibits survivin. This study highlights Tanshinone IIA as a potential ovarian cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Ovarian cancer remains a leading cause of cancer-related mortality.
- Identifying novel therapeutic agents and understanding their mechanisms are crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the anti-cancer effects of Tanshinone IIA on ovarian cancer cells in vitro.
- To elucidate the molecular mechanisms underlying Tanshinone IIA's action, focusing on apoptosis and microRNA regulation.
Main Methods:
- Cell viability was assessed using clonogenic assays.
- Apoptosis was analyzed via Annexin V/propidium iodide staining and Western blotting for apoptosis-related proteins.
- MicroRNA (miR-205) expression was quantified using real-time polymerase chain reaction.
Main Results:
- Tanshinone IIA significantly induced apoptosis in TOV-21G ovarian cancer cells.
- Tanshinone IIA suppressed survivin expression, a key apoptosis inhibitor.
- Overexpression of miR-205 was confirmed and found to inhibit survivin and promote apoptosis; its inhibition abrogated Tanshinone IIA's effects.
Conclusions:
- Tanshinone IIA induces apoptosis in ovarian cancer cells through the upregulation of miR-205.
- This mechanism involves the downregulation of survivin, highlighting Tanshinone IIA's therapeutic potential for ovarian cancer.
More Related Videos
Related Concept Videos
Ovarian Cycle
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Biological Effects of Radiation

